Page 340 - Tata_Chemicals_yearly-reports-2021-22
P. 340

Integrated Annual Report 2021-22





                                                                                                      ` in crore
                                      Net Assets i.e. total assets   Share in Profit or Loss  Share in other   Share in total
                                       minus total liabilities           comprehensive income  comprehensive income
            Sr.   Name of the Company                                         As % of            As % of
           No.                            As % of          As % of   ` in   Consolidated   ` in   Consolidated   ` in
                                      Consolidated   ` in crore Consolidated   crore  other   crore  total   crore
                                        net assets      profit or loss   comprehensive      comprehensive
                                                                              income             income
           (c)  Non-controlling Interests
               Indian Subsidiaries
               Rallis India Limited               (904.50)         (81.76)              0.32             (81.44)
               Foreign Subsidiaries
               ALCAD                                  -            (65.75)                -              (65.75)
               PT. Metahelix Lifesciences Indonesia   -               -                   -                 -
                                                 (904.50)         (147.51)             0.32             (147.19)
           (d)  Associate / Joint Ventures
               (Investment as per the Equity
               method)
               JOil (S) Pte. Ltd. and its subsidiaries   -            -                   -                 -
               The Block Salt Company Limited       0.42            (1.34)                -              (1.34)
               Indo Maroc Phosphore S.A.           672.22          308.99                 -              308.99
               Tata Industries Ltd.                561.08          (91.71)            114.02              22.31
                                                 1,233.72          215.94             114.02            329.96
           (e)  Adjustments arising out of      (19,384.96)       (582.82)             71.11            (511.71)
               Consolidation
               Consolidated                     18,252.89         1,257.62           2,959.78          4,217.40
           *value below ` 50,000/-

           49(a). Note on Ultimate Beneficiaries
           No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds)
           by the Company or its subsidiary companies and joint venture company incorporated in India to or in any other person(s) or entity(ies),
           including foreign entities (“Intermediaries”) with the understanding, whether recorded in writing or otherwise, that the Intermediary shall
           lend or invest in party identified by or on behalf of the Company or its subsidiary companies and joint venture company incorporated in
           India (Ultimate Beneficiaries).
           The Company or its subsidiary companies and joint venture company incorporated in India have not received any fund from any party(s)
           (Funding Party) with the understanding that the Company or its subsidiary companies and joint venture company incorporated in India
           shall whether, directly or indirectly lend or invest in other persons or entities identified by or on behalf of the Company or its subsidiary
           companies and joint venture company incorporated in India (“Ultimate Beneficiaries”) or provide any guarantee, security or the like on
           behalf of the Ultimate Beneficiaries.






















           338
   335   336   337   338   339   340   341   342   343   344   345